My Watchlist Items

      No Watchlist
uniQure N.V. (QURE)
   19.18   0.5400009(+2.8970008%)
TitleNamePayCurrency PayGenderYear BornTitle Since
SVice President of R&D and GM of Corlieve Mr. Richard Porter Ph.D. N/A USD male N/A N/A
Bus. Devel. Director Dr. Tamara Tugal Ph.D., MBA N/A USD N/A N/A
Chief Communications Officer Ms. Maria E. Cantor N/A USD female N/A N/A
Chief Legal Officer, Gen. Counsel & Sec. Mr. David Cerveny N/A USD male N/A N/A
Chief Operating Officer Mr. Pierre Caloz N/A USD male N/A N/A
Chairman of Scientific Advisory Board and Managing Director of UniQure-Germany Prof. Hugo Katus N/A USD N/A N/A
Pres of R&D Dr. Ricardo Dolmetsch Ph.D. 626150 USD 1969 N/A
Executive Vice President of Quality & Regulatory Dr. Alexander E. Kuta Ph.D. 652580 USD 1960 N/A
Chief Financial Officer, Principal Financial Officer & GM of Amsterdam Site Mr. Christian Klemt 392600 USD male 1973 N/A
Chief Executive Officer & Executive Director Mr. Matthew Craig Kapusta 965480 USD male 1972 N/A
SymbolDateRatingRating Score Rating Details
QURE 1 July, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 30 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 29 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 28 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 27 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 24 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 23 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 22 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 21 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 17 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 16 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 15 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 14 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 13 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 10 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 9 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 8 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 7 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 6 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 3 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 2 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 1 June, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 31 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 27 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 26 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 25 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 24 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 23 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 20 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 19 May, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 18 May, 2022 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Strong Buy)
QURE 17 May, 2022 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Strong Buy)
QURE 16 May, 2022 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Strong Buy)
QURE 13 May, 2022 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Strong Buy)
QURE 12 May, 2022 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Strong Buy)
QURE 11 May, 2022 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Strong Buy)
QURE 10 May, 2022 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Strong Buy)
QURE 9 May, 2022 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Strong Buy)
QURE 6 May, 2022 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Strong Buy)
QURE 5 May, 2022 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Strong Buy)
QURE 4 May, 2022 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Strong Buy)
QURE 3 May, 2022 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Strong Buy)
QURE 29 April, 2022 B 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Neutral)
Rating PE: (Neutral)
Rating PB: (Strong Buy)
QURE 28 April, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 27 April, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 26 April, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 25 April, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 22 April, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 21 April, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 20 April, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 19 April, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 18 April, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 14 April, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 13 April, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 12 April, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 11 April, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 8 April, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 7 April, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 6 April, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 5 April, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 4 April, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 1 April, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 31 March, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 30 March, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 29 March, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 28 March, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 25 March, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 24 March, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 23 March, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 22 March, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 21 March, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 18 March, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 17 March, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 16 March, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 15 March, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 14 March, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 11 March, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 10 March, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 9 March, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 8 March, 2022 A+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Buy)
Rating PB: (Strong Buy)
QURE 7 March, 2022 A 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Buy)
Rating PB: (Strong Buy)
QURE 4 March, 2022 A 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Buy)
Rating PB: (Strong Buy)
QURE 3 March, 2022 A 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Buy)
Rating PB: (Strong Buy)
QURE 2 March, 2022 A 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Buy)
Rating PB: (Strong Buy)
QURE 1 March, 2022 A 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Buy)
Rating PB: (Strong Buy)
QURE 28 February, 2022 A 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Buy)
Rating PB: (Strong Buy)
QURE 25 February, 2022 A 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Buy)
Rating PB: (Strong Buy)
QURE 24 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 23 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 22 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 21 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 18 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 17 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 16 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 15 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 14 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 11 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 10 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 9 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
QURE 8 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HolderSharesDate ReportedChange
STATE STREET CORP 2813416 31 March, 2022 655732
PRICE T ROWE ASSOCIATES INC /MD/ 330317 31 March, 2022 -1028392
CARLSON CAPITAL L P 78396 31 March, 2022 0
FEDERATED HERMES, INC. 594800 31 March, 2022 -848042
MILLENNIUM MANAGEMENT LLC 223688 31 March, 2022 -169983
US BANCORP \DE\ 950 31 March, 2022 351
INDEXIQ ADVISORS LLC 23146 31 March, 2022 21943
BALYASNY ASSET MANAGEMENT LLC 244487 31 March, 2022 222942
NISA INVESTMENT ADVISORS, LLC 4000 31 March, 2022 1500
TEXAS PERMANENT SCHOOL FUND 25556 31 March, 2022 -426
AQR CAPITAL MANAGEMENT LLC 66678 31 March, 2022 31471
LOS ANGELES CAPITAL MANAGEMENT LLC 26310 31 March, 2022 26310
WORTH ASSET MANAGEMENT, LLC 500 31 March, 2022 500
ALLWORTH FINANCIAL LP 164 31 March, 2022 0
EXANE DERIVATIVES 8 31 March, 2022 0
LOUISIANA STATE EMPLOYEES RETIREMENT SYSTEM 17500 31 March, 2022 100
WELLS FARGO & COMPANY/MN 20094 31 March, 2022 4977
SANDERS MORRIS HARRIS LLC 68070 31 March, 2022 0
MARYLAND STATE RETIREMENT & PENSION SYSTEM 14452 31 March, 2022 312
EVERENCE CAPITAL MANAGEMENT INC 12780 31 March, 2022 12780
NORDEA INVESTMENT MANAGEMENT AB 276375 31 March, 2022 3594
OPTIMUM INVESTMENT ADVISORS 300 31 March, 2022 0
ADAGE CAPITAL PARTNERS GP, L.L.C. 700000 31 March, 2022 100000
BLUEFIN CAPITAL MANAGEMENT, LLC 54523 31 March, 2022 54523
HENRY JAMES INTERNATIONAL MANAGEMENT INC. 125622 31 March, 2022 -30343
COVESTOR LTD 2790 31 March, 2022 2790
JEFFERIES GROUP LLC 28332 31 March, 2022 -4820
JPMORGAN CHASE & CO 884801 31 March, 2022 174050
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 29283 31 March, 2022 0
TOWER RESEARCH CAPITAL LLC (TRC) 18639 31 March, 2022 12876
SG3 MANAGEMENT, LLC 32000 31 March, 2022 22000
ANFIELD CAPITAL MANAGEMENT, LLC 546 31 March, 2022 285
DEUTSCHE BANK AG\ 102325 31 March, 2022 50000
SWISS NATIONAL BANK 82000 31 March, 2022 5700
UBS GROUP AG 210180 31 March, 2022 62551
VOYA INVESTMENT MANAGEMENT LLC 14439 31 March, 2022 0
STATE OF WYOMING 2613 31 March, 2022 1478
POINT72 ASSET MANAGEMENT, L.P. 3250300 31 March, 2022 1284780
ORBIMED ADVISORS LLC 919249 31 March, 2022 333675
CUBIST SYSTEMATIC STRATEGIES, LLC 1107 31 March, 2022 -1184
GLOBEFLEX CAPITAL L P 11131 31 March, 2022 -9239
MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. 10756 31 March, 2022 923
ZURCHER KANTONALBANK (ZURICH CANTONALBANK) 14181 31 March, 2022 -58
OREGON PUBLIC EMPLOYEES RETIREMENT FUND 13423 31 March, 2022 -400
VIRGINIA RETIREMENT SYSTEMS ET AL 44000 31 March, 2022 23400
JANE STREET GROUP, LLC 58528 31 March, 2022 18446
HARBOR CAPITAL ADVISORS, INC. 27388 31 March, 2022 -4653
AQUILO CAPITAL MANAGEMENT, LLC 901490 31 March, 2022 225284
VIRTUS ETF ADVISERS LLC 5513 31 March, 2022 -328
AXA S.A. 83600 31 March, 2022 73400
PRESTIGE WEALTH MANAGEMENT GROUP LLC 32 31 March, 2022 32
PRINCIPAL FINANCIAL GROUP INC 243006 31 March, 2022 -2458
EQIS CAPITAL MANAGEMENT, INC. 51118 31 March, 2022 3902
PDT PARTNERS, LLC 13606 31 March, 2022 -1663
DEKABANK DEUTSCHE GIROZENTRALE 39400 31 March, 2022 -3000
BLACKROCK INC. 4366736 31 March, 2022 72931
MORGAN STANLEY 1374166 31 March, 2022 132418
VOLORIDGE INVESTMENT MANAGEMENT, LLC 64005 31 March, 2022 64005
FUTURE FINANCIAL WEALTH MANAGMENT LLC 2000 31 March, 2022 0
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 181676 31 March, 2022 4474
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 2627 31 March, 2022 368
FINANCIAL GRAVITY ASSET MANAGEMENT, INC. 432 31 March, 2022 -261
ROCKEFELLER CAPITAL MANAGEMENT L.P. 92 31 March, 2022 92
ROYAL BANK OF CANADA 74770 31 March, 2022 5328
NUVEEN ASSET MANAGEMENT, LLC 35847 31 March, 2022 4967
PARALLAX VOLATILITY ADVISERS, L.P. 80945 31 March, 2022 68249
CAPTRUST FINANCIAL ADVISORS 130 31 March, 2022 -464
COMERICA BANK 28391 31 March, 2022 -315
RHUMBLINE ADVISERS 29860 31 March, 2022 4779
VOSS CAPITAL, LLC 70000 31 March, 2022 70000
NEW YORK STATE TEACHERS RETIREMENT SYSTEM 14300 31 March, 2022 3400
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 31076 31 March, 2022 3839
CAPTION MANAGEMENT, LLC 17578 31 March, 2022 -223022
PARAMETRIC PORTFOLIO ASSOCIATES LLC 114251 31 March, 2022 36580
STATE OF WISCONSIN INVESTMENT BOARD 28700 31 March, 2022 28700
GROUP ONE TRADING, L.P. 41480 31 March, 2022 -24188
FMR LLC 3793464 31 March, 2022 -546599
BANK OF MONTREAL /CAN/ 20249 31 March, 2022 10341
THRIVENT FINANCIAL FOR LUTHERANS 61249 31 March, 2022 17
SIGMA PLANNING CORP 40676 31 March, 2022 1384
WINTON GROUP LTD 67905 31 March, 2022 19734
STATE OF TENNESSEE, TREASURY DEPARTMENT 24547 31 March, 2022 1867
ACADIAN ASSET MANAGEMENT LLC 109473 31 March, 2022 98352
TUDOR INVESTMENT CORP ET AL 23070 31 March, 2022 23070
PRIVIUM FUND MANAGEMENT B.V. 493229 31 March, 2022 23196
ENDURANCE WEALTH MANAGEMENT, INC. 100 31 March, 2022 0
VANGUARD GROUP INC 1209840 31 March, 2022 30053
INVESCO LTD. 412982 31 March, 2022 -1961253
KOSHINSKI ASSET MANAGEMENT, INC. 376 31 March, 2022 0
NORTHERN TRUST CORP 126889 31 March, 2022 -5310
TCWP LLC 97 31 March, 2022 97
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 15500 31 March, 2022 0
HENNION & WALSH ASSET MANAGEMENT, INC. 63670 31 March, 2022 -2291
BANK OF AMERICA CORP /DE/ 143665 31 March, 2022 -16801
GOLDMAN SACHS GROUP INC 302690 31 March, 2022 -13967
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. 121212 31 March, 2022 -22451
VONTOBEL HOLDING LTD. 58136 31 March, 2022 -1598
WALLEYE CAPITAL LLC 19599 31 March, 2022 19599
CITIGROUP INC 154812 31 March, 2022 -29165
BEAIRD HARRIS WEALTH MANAGEMENT, LLC 152 31 March, 2022 0
EXCHANGE TRADED CONCEPTS, LLC 29602 31 March, 2022 29602
TD ASSET MANAGEMENT INC 32678 31 March, 2022 0
ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. 84905 31 March, 2022 48828
ATLAS CAPITAL ADVISORS LLC 811 31 March, 2022 0
SIMPLEX TRADING, LLC 16979 31 March, 2022 16979
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 155500 31 March, 2022 0
HSBC HOLDINGS PLC 10705 31 March, 2022 10705
MEEDER ASSET MANAGEMENT INC 1513 31 March, 2022 1513
NANTAHALA CAPITAL MANAGEMENT, LLC 2811459 31 March, 2022 448146
AMERICAN INTERNATIONAL GROUP, INC. 2754 31 March, 2022 -7
HANDELSBANKEN FONDER AB 11800 31 March, 2022 0
UBS ASSET MANAGEMENT AMERICAS INC 28320 31 March, 2022 477
ENSIGN PEAK ADVISORS, INC 13800 31 March, 2022 0
PNC FINANCIAL SERVICES GROUP, INC. 2038 31 March, 2022 1243
PARKSIDE FINANCIAL BANK & TRUST 131 31 March, 2022 0
SUSQUEHANNA INTERNATIONAL GROUP, LLP 230358 31 March, 2022 92267
ADVISOR GROUP HOLDINGS, INC. 8778 31 March, 2022 479
CREDIT SUISSE AG/ 26516 31 March, 2022 1203
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 8610 31 March, 2022 8610
BANK OF NEW YORK MELLON CORP 674565 31 March, 2022 -34458
AMERIPRISE FINANCIAL INC 487619 31 March, 2022 331509
LEGAL & GENERAL GROUP PLC 96716 31 March, 2022 -760
SKYVIEW INVESTMENT ADVISORS, LLC 834 31 March, 2022 751
PFM HEALTH SCIENCES, LP 534624 31 March, 2022 534624
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC 5194 31 March, 2022 271
CITADEL ADVISORS LLC 43734 31 March, 2022 9426
NINEPOINTTWO CAPITAL LLC 14356 31 March, 2022 0
BANQUE PICTET & CIE SA 79041 31 March, 2022 3059
AQUATIC CAPITAL MANAGEMENT LLC 100 31 March, 2022 100
PUBLIC SECTOR PENSION INVESTMENT BOARD 67450 31 March, 2022 -5950
RAFFERTY ASSET MANAGEMENT, LLC 190817 31 March, 2022 42085
CINCTIVE CAPITAL MANAGEMENT LP 79282 31 March, 2022 8900
PICTET ASSET MANAGEMENT SA 118203 31 March, 2022 32406
ENVESTNET ASSET MANAGEMENT INC 60334 31 March, 2022 8479
ASSENAGON ASSET MANAGEMENT S.A. 448985 31 March, 2022 448985
SONIC FUND II, L.P. 50000 31 March, 2022 0
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 5688 31 March, 2022 0
GENEOS WEALTH MANAGEMENT INC. 96 31 March, 2022 96
TEKLA CAPITAL MANAGEMENT LLC 521693 31 March, 2022 0
RAYMOND JAMES & ASSOCIATES 23878 31 March, 2022 -13889
MACQUARIE GROUP LTD 707141 31 March, 2022 0
683 CAPITAL MANAGEMENT, LLC 1355000 31 March, 2022 101800
CAPITAL ASSET ADVISORY SERVICES LLC 27607 31 March, 2022 7528
CUTLER GROUP LP 16562 31 March, 2022 -8200
GEODE CAPITAL MANAGEMENT, LLC 356847 31 March, 2022 -7004
HUDSON BAY CAPITAL MANAGEMENT LP 335000 31 March, 2022 45000
LAZARD ASSET MANAGEMENT LLC 10843 31 March, 2022 7634
BARCLAYS PLC 23419 31 March, 2022 20103
ADVISORNET FINANCIAL, INC 147 31 March, 2022 147
STATE OF ALASKA, DEPARTMENT OF REVENUE 25075 31 March, 2022 -440
YOUSIF CAPITAL MANAGEMENT, LLC 33144 31 March, 2022 -315
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 170000 31 March, 2022 70000
ALPS ADVISORS INC 47743 31 March, 2022 -5727
BOENNING & SCATTERGOOD, INC. 20000 31 March, 2022 0
DAIWA SECURITIES GROUP INC. 158 31 March, 2022 0
VICTORY CAPITAL MANAGEMENT INC 14992 31 March, 2022 14992
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 148898 31 March, 2022 -36302
PRUDENTIAL FINANCIAL INC 34985 31 March, 2022 -677
SG AMERICAS SECURITIES, LLC 26165 31 March, 2022 -999
AMERICAN CENTURY COMPANIES INC 217745 31 March, 2022 46528
ALLIANCEBERNSTEIN L.P. 327411 31 March, 2022 189980
SCHONFELD STRATEGIC ADVISORS LLC 53201 31 March, 2022 -870
HolderSharesDate ReportedWeight Percent
TEXAS PERMANENT SCHOOL FUND 25556 31 March, 2022 N/A
Sonic Fund II, L.P. 50000 31 March, 2022 N/A
OREGON PUBLIC EMPLOYEES RETIREMENT FUND 13423 31 March, 2022 N/A
Privium Fund Management B.V. 493229 31 March, 2022 N/A
SPHERA FUNDS MANAGEMENT LTD. 100000 31 December, 2021 N/A
HIGHLAND CAPITAL MANAGEMENT FUND ADVISORS, L.P. 23311 30 September, 2021 N/A
Verition Fund Management LLC 18334 30 September, 2021 N/A
State of New Jersey Common Pension Fund D 56973 31 December, 2020 N/A
iShares NASDAQ Biotechnology ETF 455155 31 August, 2020 0.19
iShares NASDAQ US Biotechnology UCITS ETF 12888 31 August, 2020 0.2
Fidelity MSCI Health Care Index ETF 14111 31 August, 2020 0.03
iShares Ageing Population UCITS ETF 17455 31 August, 2020 0.26
Global X Genomics & Biotechnology ETF 27541 31 August, 2020 2.07
iShares Genomics Immunology and Healthcare ETF 49248 31 August, 2020 1.3
ALPS Medical Breakthroughs ETF 55746 31 August, 2020 1.26
iShares Healthcare Innovation UCITS ETF 142671 31 August, 2020 0.43
Vanguard Health Care Index Fund 91626 31 August, 2020 0.03
CSIF (CH) III Equity World ex CH Small Cap Blue - Pension Fund 10026 31 August, 2020 0.02
BNY Mellon Small Cap Multi-Strategy Fund 46249 31 July, 2020 0.43
Invesco Oppenheimer Global Fund 1031900 31 July, 2020 0.4
Fidelity Growth Company Fund 792630 31 July, 2020 0.06
Delaware Healthcare Fund 706166 31 July, 2020 2.47
Fidelity Select Biotechnology Portfolio 670608 31 July, 2020 0.4
Fidelity Select Health Care Portfolio 400000 31 July, 2020 0.19
Fidelity Advisor Biotechnology Fund 333500 31 July, 2020 0.6
BNY Mellon Small/Mid Cap Growth Fund 289312 31 July, 2020 0.36
Fidelity Advisor Health Care Fund 254000 31 July, 2020 0.2
Invesco Oppenheimer VI Global Fund 235939 31 July, 2020 0.41
Fidelity Series Growth Company Fund 178573 31 July, 2020 0.06
Franklin Templeton Investment Funds -Biotechnology Discovery 136200 31 July, 2020 0.33
Swedbank Robur Medica 136000 31 July, 2020 0.5
Franklin Biotechnology Discovery Fund 103300 31 July, 2020 0.32
Columbia Small Cap Growth Fund I 100700 31 July, 2020 0.31
PGIM Jennison Health Sciences Fund 95788 31 July, 2020 0.21
Fidelity Growth Company K6 Fund 86352 31 July, 2020 0.07
LSP Life Sciences Fund N.V. 76394 31 July, 2020 6.54
Fidelity Stock Selector All Cap Fund 70054 31 July, 2020 0.03
Invesco Oppenheimer Main Street Small Cap Fund 69272 31 July, 2020 0.42
Invesco Oppenheimer VI Main Street Small Cap Fd 64959 31 July, 2020 0.43
BNY Mellon Opportunistic Small Cap Fund 61709 31 July, 2020 0.65
Lupus Alpha Micro Champions 56000 31 July, 2020 2.31
Fidelity VIP Health Care Portfolio 50000 31 July, 2020 0.2
Fidelity Select Pharmaceuticals Portfolio 48900 31 July, 2020 0.24
BNY Mellon Opportunistic Small Cap Port 37469 31 July, 2020 0.64
Transamerica T. Rowe Price Small Cap VP 35441 31 July, 2020 0.15
EQ/Oppenheimer Global Portfolio 32988 31 July, 2020 0.4
Invesco NASDAQ Biotech UCITS ETF 31411 31 July, 2020 0.2
EQ/Global Equity Managed Volatility Portfolio 30126 31 July, 2020 0.07
MassMutual Premier Global Fund 28966 31 July, 2020 0.4
Columbia Variable Portfolio - Small Company Growth Fund 27634 31 July, 2020 0.28
DWS Biotech 25000 31 July, 2020 0.21
BNY Mellon Mid Cap Multi-Strategy Fund 24865 31 July, 2020 0.04
Fidelity NASDAQ Composite Index Fund 24750 31 July, 2020 0.01
MassMutual Premier Small Cap Opportunities Fund 23307 31 July, 2020 0.43
Driehaus Small Cap Growth Fund 16763 31 July, 2020 0.3
Bellevue Funds (Lux) - BB Adamant Biotech 13900 31 July, 2020 0.9
Vanguard Total World Stock Index Fund 13142 31 July, 2020 N/A
Driehaus International Small Cap Growth Fund 12500 31 July, 2020 0.21
MML Small Cap Equity Fund 10809 31 July, 2020 0.43
Fidelity NASDAQ Composite Index Tracking Stock 10052 31 July, 2020 0.01
Espa Stock Biotec 34000 30 June, 2020 0.52
Putnam VT Global Health Care Fund 11000 30 June, 2020 0.35
Federated Hermes Kaufmann Small Cap Fund 1110000 30 June, 2020 0.8
JNL/Mellon Capital Healthcare Sector Fund 24153 30 June, 2020 0.03
Federated Hermes Kaufmann Fund 1870000 30 June, 2020 1.14
Met Investors Series Trust - Oppenheimer Global Equity Portfolio 126158 30 June, 2020 N/A
Putnam Global Health Care Fund 108900 30 June, 2020 0.35
Federated Unit Trust LVM ProFutur 18029 30 June, 2020 1.18
T. Rowe Price New Horizons Fund 269875 30 June, 2020 0.04
VY Invesco Oppenheimer Global Portfolio 137113 30 June, 2020 0.45
DekaLux-BioTech 17100 30 June, 2020 0.23
Federated Hermes Intl Small-Mid Company Fd 14700 30 June, 2020 0.62
T Rowe Price QM US Small-Cap Growth Equity Fund 308800 30 June, 2020 0.17
TD Health Sciences Fund 14000 30 June, 2020 0.07
Worldwide Healthcare Trust PLC 551379 30 June, 2020 1.06
Royce Smaller-Companies Growth Fund 54000 30 June, 2020 1.09
Federated Hermes Kaufmann Fund II 49300 30 June, 2020 1.35
JNL/Invesco Global Growth Fund 231390 30 June, 2020 0.46
Artisan Global Equity Fund (Ire) 48105 30 June, 2020 0.71
Brighthouse Funds Trust II -T. Rowe Price Small Cap Growth Portfolio 46800 30 June, 2020 0.16
Osterweis Emerging Opportunity Fund 43580 30 June, 2020 1.57
Lord Abbett Securities Trust - Intl Opportunities Fund 36208 30 June, 2020 0.41
Artisan Global Equity Fund (US) 35990 30 June, 2020 0.71
Vanguard Global Small-Cap Index Fund 12355 30 June, 2020 0.03
VALIC Co I Health Sciences Fund 11600 30 June, 2020 0.06
Carillon Eagle Small Cap Growth Fund 260953 30 June, 2020 0.4
JPMorgan Funds Thematics - Genetic Therapies 179494 31 May, 2020 2.44
UBS (Lux) Equity Fund - Biotech (USD) 248700 31 May, 2020 1.56
UBS (Lux) Equity SICAV - Long Term Themes (USD) 624900 31 May, 2020 1.24
BlackRock Health Sciences Trust II 127900 31 May, 2020 0.33
UBS (CH) Inst Fd 2-Eq Global Small Cap Passive II 11857 31 May, 2020 0.04
UBS (Lux) Equity Fund - Health Care (USD) 14800 31 May, 2020 0.71
New Capital US Small Cap Growth Fund 17435 31 May, 2020 1.34
Invesco Global Equity 11175 31 May, 2020 0.7
Lord Abbett Micro Cap Growth Fund 12500 30 April, 2020 0.65
Janus Henderson Triton Fund 641311 31 March, 2020 0.38
Eventide Healthcare & Life Sciences Fund 500000 31 March, 2020 2.53
Tekla Healthcare Investors 24098 31 March, 2020 0.14
Tekla Life Sciences Investors 19751 31 March, 2020 0.26
Pacific Select Developing Growth Portfolio 19617 31 March, 2020 0.49
Federated Unit Trust LVM Europa Aktien 18080 31 March, 2020 1.1
Federated Unit Trust Inter Aktien LVM 11897 31 March, 2020 0.69
MainStay VP Small Cap Growth Portfolio 32832 31 March, 2020 0.42
Polar Capital Biotechnology Fund 100000 31 December, 2019 N/A
Quadriga Investors - GFED Aequitas Fund 18056 31 December, 2019 10.19
Statens Pensjonsfond Utland 378092 31 December, 2019 N/A
Selectra Investments - J. Lamarck Biotech 13000 31 December, 2019 1.17
Salient International Small Cap Fund 19000 31 October, 2019 N/A
SymbolTransaction DateReporting CikSecurities Owned Company CikReporting NameAcquistion Or DispositionForm Type Securities TransactedSecurity NameLink
QURE 16 June, 2022 0001867944 64511 0001590560 CALOZ PIERRE D 4 7575 Ordinary Shares View
QURE 16 June, 2022 0001711885 104688 0001590560 KLEMT CHRISTIAN D 4 1687 Ordinary Shares View
QURE 15 June, 2022 0001772610 17810 0001590560 Jacques Rachelle Suzanne A 4 17810 Stock Option (Right to Buy) View
QURE 15 June, 2022 0001772610 10614 0001590560 Jacques Rachelle Suzanne A 4 9080 Ordinary Shares View
QURE 15 June, 2022 0001235862 17810 0001590560 POST LEONARD E A 4 17810 Stock Option (Right to Buy) View
QURE 15 June, 2022 0001235862 12201 0001590560 POST LEONARD E A 4 9080 Ordinary Shares View
QURE 15 June, 2022 0001376099 17810 0001590560 Kaye Jack A 4 17810 Stock Option (Right to Buy) View
QURE 15 June, 2022 0001376099 28083 0001590560 Kaye Jack A 4 9080 Ordinary Shares View
QURE 15 June, 2022 0001716268 17810 0001590560 Gut Robert A 4 17810 Stock Option (Right to Buy) View
QURE 15 June, 2022 0001716268 44165 0001590560 Gut Robert A 4 9080 Ordinary Shares View
QURE 15 June, 2022 0001692444 17810 0001590560 Soteropoulos Paula A 4 17810 Stock Option (Right to Buy) View
QURE 15 June, 2022 0001692444 16382 0001590560 Soteropoulos Paula A 4 9080 Ordinary Shares View
QURE 15 June, 2022 0001555508 17810 0001590560 Balachandran Madhavan A 4 17810 Stock Option (Right to Buy) View
QURE 15 June, 2022 0001555508 19957 0001590560 Balachandran Madhavan A 4 9080 Ordinary Shares View
QURE 15 June, 2022 0001717852 17810 0001590560 Springhorn Jeremy P. A 4 17810 Stock Option (Right to Buy) View
QURE 15 June, 2022 0001717852 19957 0001590560 Springhorn Jeremy P. A 4 9080 Ordinary Shares View
QURE 15 June, 2022 0001555337 17810 0001590560 Meek David D. A 4 17810 Stock Option (Right to Buy) View
QURE 15 June, 2022 0001555337 16460 0001590560 Meek David D. A 4 9080 Ordinary Shares View
QURE 28 February, 2022 0001235862 3121 0001590560 POST LEONARD E D 4 795 Ordinary Shares View
QURE 28 February, 2022 0001717852 10877 0001590560 Springhorn Jeremy P. D 4 602 Ordinary Shares View
QURE 28 February, 2022 0001376099 19003 0001590560 Kaye Jack D 4 600 Ordinary Shares View
QURE 28 February, 2022 0001555508 10877 0001590560 Balachandran Madhavan D 4 602 Ordinary Shares View
QURE 28 February, 2022 0001555337 7380 0001590560 Meek David D. D 4 602 Ordinary Shares View
QURE 28 February, 2022 0001692444 7302 0001590560 Soteropoulos Paula D 4 596 Ordinary Shares View
QURE 28 February, 2022 0001536290 360554 0001590560 Kapusta Matthew C D 4 10195 Ordinary Shares View
QURE 28 February, 2022 0001711885 106375 0001590560 KLEMT CHRISTIAN D 4 4075 Ordinary Shares View
QURE 28 February, 2022 0001825206 122325 0001590560 Dolmetsch Ricardo D 4 1484 Ordinary Shares View
QURE 28 February, 2022 0001716268 35085 0001590560 Gut Robert D 4 1602 Ordinary Shares View
QURE 28 February, 2022 0001696698 95156 0001590560 Kuta Alexander Edward III D 4 3405 Ordinary Shares View
QURE 24 February, 2022 0001235862 2645 0001590560 POST LEONARD E A 4 2645 Stock Option (Right to Buy) View
QURE 24 February, 2022 0001235862 3916 0001590560 POST LEONARD E A 4 1534 Ordinary Shares View
QURE 24 February, 2022 0001376099 2645 0001590560 Kaye Jack A 4 2645 Stock Option (Right to Buy) View
QURE 24 February, 2022 0001376099 19603 0001590560 Kaye Jack A 4 1534 Ordinary Shares View
QURE 24 February, 2022 0001555337 2645 0001590560 Meek David D. A 4 2645 Stock Option (Right to Buy) View
QURE 24 February, 2022 0001555337 7982 0001590560 Meek David D. A 4 1534 Ordinary Shares View
QURE 24 February, 2022 0001717852 2645 0001590560 Springhorn Jeremy P. A 4 2645 Stock Option (Right to Buy) View
QURE 24 February, 2022 0001717852 11479 0001590560 Springhorn Jeremy P. A 4 1534 Ordinary Shares View
QURE 24 February, 2022 0001555508 2645 0001590560 Balachandran Madhavan A 4 2645 Stock Option (Right to Buy) View
QURE 24 February, 2022 0001555508 11479 0001590560 Balachandran Madhavan A 4 1534 Ordinary Shares View
QURE 24 February, 2022 0001692444 2645 0001590560 Soteropoulos Paula A 4 2645 Stock Option (Right to Buy) View
QURE 24 February, 2022 0001692444 7898 0001590560 Soteropoulos Paula A 4 1534 Ordinary Shares View
QURE 24 February, 2022 0001772610 2645 0001590560 Jacques Rachelle Suzanne A 4 2645 Stock Option (Right to Buy) View
QURE 24 February, 2022 0001772610 1534 0001590560 Jacques Rachelle Suzanne A 4 1534 Ordinary Shares View
QURE 24 February, 2022 0001825206 94281 0001590560 Dolmetsch Ricardo A 4 94281 Stock Option (Right to Buy) View
QURE 24 February, 2022 0001825206 123809 0001590560 Dolmetsch Ricardo A 4 54683 Ordinary Shares View
QURE 24 February, 2022 0001696698 60179 0001590560 Kuta Alexander Edward III A 4 60179 Stock Option (Right to Buy) View
QURE 24 February, 2022 0001696698 98601 0001590560 Kuta Alexander Edward III A 4 34904 Ordinary Shares View
QURE 24 February, 2022 0001867944 63941 0001590560 CALOZ PIERRE A 4 63941 Stock Option (Right to Buy) View
QURE 24 February, 2022 0001867944 72086 0001590560 CALOZ PIERRE A 4 37086 Ordinary Shares View
QURE 24 February, 2022 0001711885 75224 0001590560 KLEMT CHRISTIAN A 4 75224 Stock Option (Right to Buy) View
QURE 24 February, 2022 0001711885 110450 0001590560 KLEMT CHRISTIAN A 4 43630 Ordinary Shares View
QURE 24 February, 2022 0001536290 215643 0001590560 Kapusta Matthew C A 4 215643 Stock Option (Right to Buy) View
QURE 24 February, 2022 0001536290 370749 0001590560 Kapusta Matthew C A 4 125073 Ordinary Shares View
QURE 24 February, 2022 0001716268 2645 0001590560 Gut Robert A 4 2645 Stock Option (Right to Buy) View
QURE 24 February, 2022 0001716268 36687 0001590560 Gut Robert A 4 1534 Ordinary Shares View
QURE 26 January, 2022 0001716268 35153 0001590560 Gut Robert D 4 2348 Ordinary Shares View
QURE 26 January, 2022 0001696698 63697 0001590560 Kuta Alexander Edward III D 4 2945 Ordinary Shares View
QURE 26 January, 2022 0001711885 66820 0001590560 KLEMT CHRISTIAN D 4 3963 Ordinary Shares View
QURE 26 January, 2022 0001536290 245676 0001590560 Kapusta Matthew C D 4 10901 Ordinary Shares View
QURE 15 December, 2021 0001696698 44000 0001590560 Kuta Alexander Edward III D 4 6000 Stock Option (Right to Buy) View
QURE 15 December, 2021 0001696698 66642 0001590560 Kuta Alexander Edward III D 4 6000 Ordinary Shares View
QURE 15 December, 2021 0001696698 72642 0001590560 Kuta Alexander Edward III A 4 6000 Ordinary Shares View
QURE 15 November, 2021 0001696698 50000 0001590560 Kuta Alexander Edward III D 4 6000 Stock Option (Right to Buy) View
QURE 15 November, 2021 0001696698 66642 0001590560 Kuta Alexander Edward III D 4 6000 Ordinary Shares View
QURE 15 November, 2021 0001696698 72642 0001590560 Kuta Alexander Edward III A 4 6000 Ordinary Shares View
QURE 21 October, 2021 0001772610 10000 0001590560 Jacques Rachelle Suzanne A 4 10000 Stock Option (Right to Buy) View
QURE 15 October, 2021 0001696698 56000 0001590560 Kuta Alexander Edward III D 4 6000 Stock Option (Right to Buy) View
QURE 15 October, 2021 0001696698 66642 0001590560 Kuta Alexander Edward III D 4 6000 Ordinary Shares View
QURE 15 October, 2021 0001696698 72642 0001590560 Kuta Alexander Edward III A 4 6000 Ordinary Shares View
QURE 21 September, 2021 0001711885 70783 0001590560 KLEMT CHRISTIAN D 4 2400 Ordinary Shares View
QURE 21 September, 2021 0001716268 37501 0001590560 Gut Robert D 4 4500 Ordinary Shares View
QURE 21 September, 2021 0001696698 66642 0001590560 Kuta Alexander Edward III D 4 2229 Ordinary Shares View
QURE 16 September, 2021 0001825206 69126 0001590560 Dolmetsch Ricardo D 4 8603 Ordinary Shares View
QURE 15 September, 2021 0001696698 74871 0001590560 Kuta Alexander Edward III A 4 6000 Ordinary Shares View
QURE 15 September, 2021 0001696698 62000 0001590560 Kuta Alexander Edward III D 4 6000 Stock Option (Right to Buy) View
QURE 15 September, 2021 0001696698 74871 0001590560 Kuta Alexander Edward III A 4 6000 Stock Option (Right to Buy) View
QURE 15 September, 2021 0001696698 68871 0001590560 Kuta Alexander Edward III D 4 6000 Ordinary Shares View
QURE 15 September, 2021 0001696698 68871 0001590560 Kuta Alexander Edward III D 4 6000 Stock Option (Right to Buy) View
QURE 18 August, 2021 0001536290 256577 0001590560 Kapusta Matthew C D 4 117 Ordinary Shares View
QURE 18 August, 2021 0001536290 256694 0001590560 Kapusta Matthew C D 4 883 Ordinary Shares View
QURE 16 August, 2021 0001696698 74871 0001590560 Kuta Alexander Edward III A 4 6000 Ordinary Shares View
QURE 16 August, 2021 0001696698 68871 0001590560 Kuta Alexander Edward III D 4 6000 Ordinary Shares View
QURE 16 August, 2021 0001696698 68000 0001590560 Kuta Alexander Edward III D 4 6000 Stock Option (Right to Buy) View
QURE 15 July, 2021 0001696698 74000 0001590560 Kuta Alexander Edward III D 4 6000 Stock Option (Right to Buy) View
QURE 15 July, 2021 0001696698 74871 0001590560 Kuta Alexander Edward III A 4 6000 Ordinary Shares View
QURE 15 July, 2021 0001696698 68871 0001590560 Kuta Alexander Edward III D 4 6000 Ordinary Shares View
QURE 14 July, 2021 0001536290 257577 0001590560 Kapusta Matthew C D 4 1000 Ordinary Shares View
QURE 17 June, 2021 0001536290 258577 0001590560 Kapusta Matthew C D 4 1900 Ordinary Shares View
QURE 16 June, 2021 0001536290 262470 0001590560 Kapusta Matthew C D 4 1457 Ordinary Shares View
QURE 16 June, 2021 0001536290 260477 0001590560 Kapusta Matthew C D 4 1993 Ordinary Shares View
QURE 15 June, 2021 0001696698 74871 0001590560 Kuta Alexander Edward III A 4 6000 Ordinary Shares View
QURE 15 June, 2021 0001696698 68871 0001590560 Kuta Alexander Edward III D 4 6000 Ordinary Shares View
QURE 15 June, 2021 0001696698 80000 0001590560 Kuta Alexander Edward III D 4 6000 Stock Option (Right to Buy) View
QURE 15 June, 2021 0001711885 73183 0001590560 KLEMT CHRISTIAN A 4 9579 Ordinary Shares View
QURE 15 June, 2021 0001711885 16235 0001590560 KLEMT CHRISTIAN A 4 16235 Stock Option (Right to Buy) View
QURE 15 June, 2021 0001867944 10000 0001590560 CALOZ PIERRE A 4 10000 Stock option (Right to Buy) View
QURE 15 June, 2021 0001867944 35000 0001590560 CALOZ PIERRE A 4 25000 Ordinary Shares View
QURE 15 June, 2021 0001867944 75000 0001590560 CALOZ PIERRE A 4 75000 Stock option (Right to Buy) View
QURE 17 May, 2021 0001696698 74871 0001590560 Kuta Alexander Edward III A 4 6000 Ordinary Shares View
QURE 17 May, 2021 0001696698 86000 0001590560 Kuta Alexander Edward III D 4 6000 Stock Option (Right to Buy) View
SymbolDatePeriodDownload XLSX File
QURE 2020 FY Download XLSX File
QURE 2019 FY Download XLSX File
QURE 2018 FY Download XLSX File
QURE 2017 FY Download XLSX File
QURE 2016 FY Download XLSX File
QURE 2021 Q3 Download XLSX File
QURE 2021 Q1 Download XLSX File
QURE 2021 Q2 Download XLSX File
QURE 2020 Q1 Download XLSX File
QURE 2020 Q4 Download XLSX File
QURE 2020 Q3 Download XLSX File
QURE 2020 Q2 Download XLSX File
QURE 2019 Q2 Download XLSX File
QURE 2019 Q1 Download XLSX File
QURE 2019 Q3 Download XLSX File
QURE 2019 Q4 Download XLSX File
QURE 2018 Q1 Download XLSX File
QURE 2018 Q3 Download XLSX File
QURE 2018 Q4 Download XLSX File
QURE 2018 Q2 Download XLSX File
QURE 2017 Q2 Download XLSX File
QURE 2017 Q1 Download XLSX File
QURE 2017 Q4 Download XLSX File
QURE 2017 Q3 Download XLSX File
QURE 2016 Q4 Download XLSX File

Charts

Company Historical Earnings

DateSymbolEPSEPS EstimatedTimeRevenueRevenue Estimated
25 July, 2022 QURE bmo 0 10190000
2 May, 2022 QURE -1 -1 bmo 1792000000 0
25 February, 2022 QURE 0.18 0.18 bmo 57691000 27560000
25 October, 2021 QURE -0.79 -0.79 bmo 1989000 2520000
26 July, 2021 QURE 8.51 8.51 bmo 463868000 2520000
10 May, 2021 QURE -0.91 -0.91 bmo 454000 438522
1 March, 2021 QURE -0.01 -0.01 bmo 34086000 0
27 October, 2020 QURE -1.21 -1.21 bmo 1789000 2676107.4380165
30 July, 2020 QURE -0.96 -0.96 bmo 1535000 1071302.0833333
29 April, 2020 QURE -0.63 -0.63 bmo 104000 138666.66666667
2 March, 2020 QURE -0.96 -0.96 bmo 2625000 79083.333333333
28 October, 2019 QURE -0.58 -0.58 bmo 1046000 1460793.1034483
29 July, 2019 QURE -0.83 -0.83 bmo 2474000 2235542.1686747
29 April, 2019 QURE -0.74 -0.74 bmo 1136000 1089945.9459459
28 February, 2019 QURE -0.59 -0.59 bmo 1608000 1798779.6610169
6 November, 2018 QURE -0.59 -0.59 bmo 3148000 3308067.7966102
8 August, 2018 QURE -0.57 -0.57 bmo 3050000 3264035.0877193
30 April, 2018 QURE -0.59 -0.59 bmo 3478000 4362237.2881356
14 March, 2018 QURE -0.91 -0.91 bmo 2584000 2942923.0769231
1 November, 2017 QURE -0.4 -0.4 bmo 2260000 3559500
8 August, 2017 QURE -0.83 -0.83 bmo 4942000 4703831.3253012
9 May, 2017 QURE -0.8 -0.8 bmo 3321000 2739825
15 March, 2017 QURE -0.54 -0.54 bmo 9045002.333513 0
22 November, 2016 QURE -0.61 -0.61 bmo 7254083.64746 9240320
25 August, 2016 QURE -0.85 -0.85 bmo 4383710.970957 4533155
31 May, 2016 QURE -0.94 -0.94 bmo 4422231.288816 3712490
4 April, 2016 QURE -0.63 -0.63 bmo 4422231.288816 4806773
30 November, 2015 QURE -1.21 -1.21 bmo 3544383.558561 3223296.28125
27 August, 2015 QURE -0.97 -0.97 bmo 1811391.013706 6135675
11 June, 2015 QURE -0.74 -0.74 bmo 1198791.462266 0
6 April, 2015 QURE -0.64 -0.64 bmo 1198791.462266 1027535
1 December, 2014 QURE -0.54 -0.54 bmo 1270175.616689 0
2 September, 2014 QURE -0.51 -0.51 bmo 1421594.040765 0
6 June, 2014 QURE -0.71 -0.71 bmo 1609132.16889 0

Company Profile

Company Name uniQure N.V.
Symbol QURE
Currency USD
Price 19.18
Exchange Name NASDAQ Global Select (NASDAQ)
Industry Biotechnology
CEO Mr. Matthew Craig Kapusta
Sector Healthcare
Country NL
Full Time Employees 463
Phone 31202406000
Address Paasheuvelweg 25a
City AMSTERDAM
State NOORD-HOLLAND
Zip 1105 BP
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phase I/II clinical trial for the treatment of hemophilia B; AMT-210, a product candidate for the treatment of Parkinson's disease; AMT-260 for temporal lobe epilepsy; AMT-240, a preclinical product candidate for the treatment of autosomal dominant Alzheimer's disease; and AMT-161 for the treatment of amyotrophic lateral sclerosis. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
>

FREE

Get the most important news and analyses for Free.

Thank you for subscribing.

Something went wrong.